Monday, September 21, 2020
Home Life Style Health & Fitness Drugs That Treat Arthritis in Dogs Can Kill Cancer Cells: Study

Drugs That Treat Arthritis in Dogs Can Kill Cancer Cells: Study

Drug for arthritis in dogs can fight cancer in people

Drugs for diabetes, inflammation, alcoholism — and even for treating arthritis in dogs — can also kill cancer cells in the lab, according to a new health news and study.

The researchers systematically analysed thousands of already developed drug compounds and found nearly 50 that have previously unrecognised anti-cancer activity.

The findings, which also revealed novel drug mechanisms and targets, suggest a possible way to accelerate the development of new cancer drugs or repurpose existing drugs to treat cancer.

“We thought we’d be lucky if we found even a single compound with anti-cancer properties, but we were surprised to find so many,” said study researcher Todd Golub from Harvard University in the US.

Cancer Cells
Most of the non-oncology drugs that killed cancer cells in the study did so by interacting with a previously unrecognized molecular target. (Representational Image). Pixabay

The study, published in the journal Nature Cancer, yet to employ the Broad’s Drug Repurposing Hub, a collection that currently comprises more than 6,000 existing drugs and compounds that are either FDA-approved or have been proven safe in clinical trials (at the time of the study, the Hub contained 4,518 drugs).

Historically, scientists have stumbled upon new uses for a few existing medicines, such as the discovery of aspirin’s cardiovascular benefits.

“We created the repurposing hub to enable researchers to make these kinds of serendipitous discoveries in a more deliberate way,” said study first author Steven Corsello, from Dana-Farber Cancer Institute and founder of the Drug Repurposing Hub.

The researchers tested all the compounds in the Drug Repurposing Hub on 578 human cancer cell lines from the Broad’s Cancer Cell Line Encyclopedia (CCLE).

Using a molecular barcoding method known as PRISM, which was developed in the Golub lab, the researchers tagged each cell line with a DNA barcode, allowing them to pool several cell lines together in each dish and more quickly conduct a larger experiment.

The team then exposed each pool of barcoded cells to a single compound from the repurposing library, and measured the survival rate of the cancer cells.

They found nearly 50 non-cancer drugs — including those initially developed to lower cholesterol or reduce inflammation — that killed some cancer cells while leaving others alone.

Some of the compounds killed cancer cells in unexpected ways.

“Most existing cancer drugs work by blocking proteins, but we’re finding that compounds can act through other mechanisms,” said Corsello.

Cancer Cells
The researchers tested all the compounds in the Drug Repurposing Hub on 578 human cancer cells lines from the Broad’s Cancer Cell Line Encyclopedia. (Representational Image). Pixabay

Some of the four-dozen drugs researchers identified appear to act not by inhibiting a protein but by activating a protein or stabilising a protein-protein interaction.

For example, the team found that nearly a dozen non-oncology drugs killed cancer cells that express a protein called PDE3A by stabilising the interaction between PDE3A and another protein called SLFN12 — a previously unknown mechanism for some of these drugs.

These unexpected drug mechanisms were easier to find using the study’s cell-based approach, which measures cell survival, than through traditional non-cell-based high-throughput screening methods, Corsello said.

Also Read- Mothers Find Gaps in Accessibility of Breastfeeding Resources at Work: Research

Most of the non-oncology drugs that killed cancer cells in the study did so by interacting with a previously unrecognized molecular target.

For example, the anti-inflammatory drug tepoxalin, originally developed for use in people but approved for treating osteoarthritis in dogs, killed cancer cells by hitting an unknown target in cells that overexpress the protein MDR1, which commonly drives resistance to chemotherapy drugs. (IANS)

STAY CONNECTED

19,146FansLike
362FollowersFollow
1,774FollowersFollow

Most Popular

Ketogenic Diet May Reduce Risk of Alzheimer’s Disease

Eating healthy, low calorie food could help fight the fungi in the gut and thus reduce the risk of dementia among senior citizens, doctors...

45% of the Top 100 Google Searches Related to Travel Amid Pandemic

After living months in isolation during the pandemic, the travel bug has hit millions of people and according to Google, 45 per cent of...

Bollywood Kills, Sexually Abuses: Debates Parliament

Bollywood kills, Bollywood sexually abuses', were some of the allegations that resonated in the Parliament House complex on Monday. BJP Rajya Sabha member Roopa Ganguly,...

This Breast Cancer Drug May Help Prostate Cancer Patients

A drug used to treat breast and ovarian cancer can extend the lives of some men with prostate cancer, showed results of a major...

Let’s Celebrate World Alzheimer’s Day!

World Alzheimer's Day is observed every year on September 21. The Alzheimer's disease is seen in people especially after 65 years of age where...

Breathing: One of the Most Common Ways by Which Coronavirus is Spread

As the United States nears 200,000 deaths from COVID-19, the Centers for Disease Control and Prevention updated its guidelines to add breathing to the...

Bevli Has An Infectious Enthusiasm Towards Plogging

When eco-fitness enthusiast Ripu Daman Bevli started to pick trash off the streets alongside his jogging regimen, a few years ago, people would curiously...

The Mode Of Imparting Education Leads Educators To Fend For Themselves: Innovator Krishna

Gaps in universality of the mode of imparting education often leads educators to fend for themselves and figure out things on their own, says...

Recent Comments